Skip to main content

Bristol Myers Squibb statistics

  • BMY · NYSE
  • Pharmaceuticals
  • S&P 500
$63.43+1.78%Close 13 Nov 2026 · Market value $128.5B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Bristol Myers Squibb is valued at $128.5B on its latest close. Its price is 13.9 times its earnings.

Market value$128.5B
Enterprise value$162.7B
Price / earnings13.91
Price / sales2.57
Price / book5.49
EV / EBITDA11.31
EV / sales3.25
Price / free cash flow13.84
Price / free cash flow, own 5-year average9.54
EV / EBIT13.98
EV / free cash flow17.39
Free cash flow yield7.2%
Dividend yield4.0%

Share price

Latest close$63.43
Day's change+1.8%
52-week high$68.64
52-week low$45.27
From 52-week high−7.6%
Return · 1 month+6.2%
Return · 3 months−3.1%
Return · year to date+17.6%
Return · 1 year+29.2%
Beta · 1 year against the S&P 5000.23
50-day average$61.90
200-day average$60.34
RSI 1455.8
Average volume · 20 sessions10.1M

Margins and returns

For fiscal 2025, as filed.

Gross margin71.1%
Operating margin20.8%
Net margin14.6%
Free cash flow margin26.7%
Return on equity40.5%
Return on assets8.3%
Return on invested capital11.5%
Return on invested capital, 5-year average5.5%
Return on capital employed14.8%
Stock-based compensation / revenue1.1%

Financial position

At the end of fiscal 2025.

Cash and equivalents$10.21B
Total debt$49.12B
Net debt$38.44B
Current ratio1.26
Quick ratio1.16
Debt / equity2.66
Net debt / EBITDA2.74
Interest coverage5.29

Growth

Revenue, latest quarter on a year+6.9%
Revenue, twelve months on a year+4.2%
EPS, latest quarter on a year−2.8%
EPS, twelve months on a year+52.3%
Revenue, 5-year compound+2.5%
Revenue, 10-year compound+11.3%
Free cash flow, 5-year compound−0.7%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares2.0B
Shares outstanding, 5-year compound−2.0%
Net share repurchases$0.00
Dividends per share$2.49
Dividend payout71.5%

Taxes

For fiscal 2025, as filed.

Income tax expense$2.27B
Effective tax rate24.4%

BMY in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.